• Viral Control of RIPK3 Degradation Shapes Host Inflammatory

  2026-07-24

  This study uncovers a class of viral proteins that induce degradation of the necroptosis adaptor RIPK3, allowing orthopoxviruses such as cowpox virus to suppress host inflammatory cell death. The findings reveal how targeted manipulation of ubiquitin pathways by viruses regulates inflammation and pathogenesis, with implications for future antiviral and immunology research.

• Viral Induction of RIPK3 Degradation Modulates Necroptosis

  2026-07-24

  Liu et al. identified a class of orthopoxvirus proteins that induce targeted degradation of RIPK3, thereby suppressing necroptosis and modulating virus-induced inflammation. This mechanistic insight advances our understanding of host-pathogen interactions and highlights the central role of the ubiquitin-proteasome system in regulating antiviral immune responses.

• Gramine Induces Ferroptosis via CUL3–MTDH Axis in TNBC Model

  2026-07-23

  A recent study demonstrates that Gramine (1-(1H-indol-3-yl)-N,N-dimethylmethanamine) selectively suppresses triple-negative breast cancer by triggering ferroptosis through CUL3-mediated ubiquitination of MTDH. These findings establish a mechanistic basis for using Gramine as a research tool to interrogate ferroptosis pathways in aggressive cancer subtypes.

• MLN4924: NEDD8-Activating Enzyme Inhibitor for Cancer Models

  2026-07-23

  MLN4924 is a highly selective NEDD8-activating enzyme inhibitor, empowering cancer researchers to dissect the neddylation pathway and block cullin-RING ligase-mediated degradation with precision. Explore optimized workflows, practical troubleshooting, and cutting-edge applications that make MLN4924 from APExBIO indispensable for translational oncology.

• Etomoxir: Strategic Insights for Translational Immunometabol

  2026-07-22

  This thought-leadership article unpacks the mechanistic and translational value of Etomoxir (R-(+)-Etomoxir) in immunometabolic research. We connect the dots between CPT-1 inhibition, immune modulation, and standardized whole-blood assays, offering actionable guidance and forward-looking perspectives for researchers seeking to bridge basic science and clinical innovation.

• Gramine: Applied Ferroptosis Inducer for TNBC Research Workf

  2026-07-22

  Gramine (1-(1H-indol-3-yl)-N,N-dimethylmethanamine) offers researchers a validated, high-purity tool to induce ferroptosis in triple-negative breast cancer (TNBC) models. This guide translates recent mechanistic breakthroughs into actionable workflows, protocol enhancements, and expert troubleshooting for reproducible cancer biology research.

• WST-8 Glucose Uptake Assay Kit: Decoding Autophagy and Insul

  2026-07-21

  Explore how the WST-8 Glucose Uptake Assay Kit enables precise, non-radioactive glucose uptake quantification while illuminating the intersection of autophagy and insulin resistance in metabolic research. This article uniquely connects biochemical assay optimization to cutting-edge discoveries in NAFLD pathogenesis.

• D-N-Acetylgalactosamine: Technical Use in Brain Glycoprotein

  2026-07-21

  D-N-Acetylgalactosamine is used as a high-purity, water-soluble standard for investigating glycoprotein structures and glycosylation pathways in brain tissue. It should not be used in workflows requiring ethanol solubility or long-term storage of solutions. Adherence to recommended storage and handling is critical for experimental reliability.

• PR-619: Practical Guide to Broad-Spectrum DUB Inhibition

  2026-07-20

  PR-619 is a cell-permeable, reversible deubiquitylating enzymes inhibitor designed for broad-spectrum DUB targeting in ubiquitination pathway research. It is especially suited for cell-based assays exploring protein ubiquitination, autophagy dynamics, and disease models in cancer biology or neurodegeneration. This compound should not be used as a proteasome inhibitor substitute and is recommended where selective DUB inhibition is required.

• Lovastatin (SKU A4365): Assay Precision for Cell Viability a

  2026-07-20

  This article delivers a scenario-driven, evidence-based guide to deploying Lovastatin (SKU A4365) in cell viability, proliferation, and cytotoxicity assays. By addressing real laboratory questions, it demonstrates how APExBIO's Lovastatin provides reproducible, quantitative solutions for biomedical research teams seeking robust mechanistic insight and protocol optimization.

• CD28-ARS2 Axis Drives Metabolic Flexibility in CD8+ T Cells

  2026-07-19

  This article examines how the CD28-ARS2 axis regulates alternative splicing of pyruvate kinase isoforms to enhance metabolic flexibility in CD8+ T cells, thereby supporting robust antitumor immunity. The findings clarify a previously unrecognized mechanism of immunometabolic adaptation and suggest new avenues for immune-based therapies.

• U0126-EtOH: Mechanistic Insights and Assay Optimization in M

  2026-07-18

  Delve into the mechanistic depth and practical assay guidance for U0126-EtOH, a highly selective MEK1/2 inhibitor. This article uniquely integrates reference-driven insights with advanced protocol optimization for cutting-edge neuroprotection and inflammation research.

• Cyclosporin A: Applied Workflows for Immune and Mitochondria

  2026-07-17

  Cyclosporin A bridges immunosuppression with mitochondrial modulation, enabling advanced cell death and disease modeling protocols. This article details optimized workflows, troubleshooting guides, and novel insights from recent research—empowering scientists to maximize experimental clarity and translational value.

• MLN4924 HCl Salt: Enabling Precision NEDD8 Pathway Inhibitio

  2026-07-17

  MLN4924 HCl salt empowers researchers to dissect the neddylation pathway with high specificity, transforming the study of protein degradation and immune evasion. With its robust inhibition of NEDD8-activating enzyme, it delivers actionable workflow enhancements for cancer biology and virology research.

• Optimizing MAPK/ERK Pathway Research with U0126-EtOH (A1337)

  2026-07-16

  This article provides scenario-driven guidance for biomedical researchers seeking reliable, reproducible modulation of the MAPK/ERK pathway using U0126-EtOH (SKU A1337). Drawing on peer-reviewed evidence and best practices, it addresses common challenges—such as assay reproducibility, protocol optimization, and vendor selection—while highlighting U0126-EtOH’s validated performance in cell viability and oxidative stress assays.

16664 records 1/1111 page Next 12345 下5页 Last page